The value of expert second opinion in diagnosis of soft tissue sarcomas

Journal of Surgical Oncology

Volumn 97, Issue 1, 2008, Pages 40-43

  Lehnhardt, Marcus ^a   Daigeler, Adrien ^a   Hauser, Joerg ^a   Puls, Alexander ^a   Soimaru, Christian ^a   Kuhnen, Cornelius ^a   Steinau, Hans Ulrich ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Classification; Histology; Histopathology; Reference histology; Soft tissue sarcoma

Indexed keywords

ADULT; CANCER GRADING; CONFERENCE PAPER; CONSULTATION; DIAGNOSTIC VALUE; FEMALE; FIBROMATOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; SYSTEMIC THERAPY; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EXPERT TESTIMONY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SARCOMA;

EID: 38149012288     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20897     Document Type: Conference Paper

References (29)

1. Borden EC, Baker LH, Bell RS, et al.: Soft tissue sarcomas of adults: State of the translational science. Clin Cancer Res 2003; 9:1941-1956.
2. Singer S, Demetri GD, Baldini EH, et al.: Management of soft-tissue sarcomas: An overview and update. Lancet Oncol 2000;1:75-85.
3. Nielsen TO, West RB, Linn SC, et al.: Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 2002;359:1301-1307.
4. Toro JR, Travis LB, Wu HJ, et al.: Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer 2006;119:2922-2930.
5. Reichardt P: High-dose chemotherapy in adult soft tissue sarcoma. Crit Rev Oncol Hematol 2002;41:157-1567.
6. Steinau HU, Homann HH, Drucke D, et al.: Resection method and functional restoration in soft tissue sarcomas of the extremities. Chirurg 2001;72:501-513.
7. Steinau HU, Soimaru C, Puls A, et al.: Chirurgische Onkologie der Weichgewebssarkome. Ist eine Referenzpathologie erforderlich? Deutsche Gesellschaft für Chirurgie. Kongressband 2002;365:463 (ISBN 3-540-44330-4).
8. Abt AB, Abt LG, Olt GJ: The effect of interinstitution anatomic pathology consultation on patient care. Arch Pathol Lab Med 1995;119:514-517.
9. Kronz JD, Westra WH, Epstein JI: Mandatory second opinion surgical pathology at a large referral hospital. Cancer 1999;86:2426-2435.
10. Tomaszewski JE, Bear HD, Connally JA, et al.: Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol 2000;114:329-335.
11. Arbiser ZK, Folpe AL, Weiss SW: Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol 2001;116:473-476.
12. Katenkamp D: Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas. Pathol Res Pract 1988;183:698-705.
13. Fletcher CD: The evolving classification of soft tissue tumours: An update based on the new WHO classification. Histopathology 2006;48:3-12.
14. Germann G, Bruner S: Plastic surgery reconstruction of the trunk area after resection of malignant tumours and therapy sequelae. Chirurg 2001;72:514-522.
15. Lehnhardt M, Kuhnen C, Drucke D, et al.: Liposarcoma of the extremities: Recent developments in surgical therapy. Analysis of 167 patients. Chirurg 2004;75:1182-1190.
16. Enzinger FM, Weiss SW: Soft tissue tumours, 4th edition. St. Louis: Mosby; 2001.
17. Singer S, Corson JM, Demetri GD, et al.: Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995;221:185-195.
18. Singer S, Baldini EH, Demetri GD, et al.: Synovial sarcoma: Prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 1996;14:1201-1208.
19. Fernberg JO, Hall KS: Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 2004;75:77-86.
20. Clarkson P, Ferguson PC: Management of soft tissue sarcomas of the extremities. Expert Rev Anticancer Ther 2004;4:237-246.
21. Cormier JN, Langstein HN, Pisters PW: Preoperative therapy for soft tissue sarcoma. Cancer Treat Res 2004;120:43-63.
22. Hui AC, Ngan SY, Wong K, et al.: Preoperative radiotherapy for soft tissue sarcoma: The Peter MacCallum Cancer Centre experience. Eur J Surg Oncol 2006;32:1159-1164.
23. Nedea EA, DeLaney TF: Sarcoma and skin radiation oncology. Hematol Oncol Clin North Am 2006;20:401-429.
24. Coindre JM, Nguyen BB, Goussot JF, et al.: Histological changes after chemotherapy of soft tissue sarcomas in the adult. Ann Pathol 1985;5:95-99.
25. Coindre JM, Trojani M, Contesso G, et al.: Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58:306-309.
26. Harris M, Hartley AL, Blair V, et al.: Sarcomas in north west England: I. Histopathological peer review. Br J Cancer 1991;64:315-320.
27. Westra WH, Kronz JD, Eisele DW: The impact of second opinion surgical pathology on the practice of head and neck surgery: A decade experience at a large referral hospital. Head Neck 2002;24:684-693.
28. Zhang P, Brooks JS: Modern pathological evaluation of soft tissue sarcoma specimens and its potential role in soft tissue sarcoma research. Curr Treat Options Oncol 2004;5:441-450.
29. Presant CA, Russell WO, Alexander RW, et al.: Soft-tissue and bone sarcoma histopathology peer review: The frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol 1986;4:1658-1661.